These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35116771)

  • 21. Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma.
    Yun HJ; Kim HJ; Kim SY; Lee YS; Lim CY; Chang HS; Park CS
    Front Endocrinol (Lausanne); 2021; 12():585364. PubMed ID: 33746898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Watson for oncology decision system for treatment consistency study in breast cancer.
    Liu Y; Huo X; Li Q; Li Y; Shen G; Wang M; Ren D; Zhao F; Liu Z; Zhao J; Liu X
    Clin Exp Med; 2023 Sep; 23(5):1649-1657. PubMed ID: 36138331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering.
    Hamilton JG; Genoff Garzon M; Westerman JS; Shuk E; Hay JL; Walters C; Elkin E; Bertelsen C; Cho J; Daly B; Gucalp A; Seidman AD; Zauderer MG; Epstein AS; Kris MG
    J Oncol Pract; 2019 Apr; 15(4):e277-e288. PubMed ID: 30689492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of Watson for Oncology in clinical application.
    Jie Z; Zhiying Z; Li L
    Sci Rep; 2021 Mar; 11(1):5792. PubMed ID: 33707577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of an oncology clinical decision-support system's recommendations with actual treatment decisions.
    Suwanvecho S; Suwanrusme H; Jirakulaporn T; Issarachai S; Taechakraichana N; Lungchukiet P; Decha W; Boonpakdee W; Thanakarn N; Wongrattananon P; Preininger AM; Solomon M; Wang S; Hekmat R; Dankwa-Mullan I; Shortliffe E; Patel VL; Arriaga Y; Jackson GP; Kiatikajornthada N
    J Am Med Inform Assoc; 2021 Mar; 28(4):832-838. PubMed ID: 33517389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance Study in Hepatectomy Recommendations Between Watson for Oncology and Clinical Practice for Patients with Hepatocellular Carcinoma in China.
    Zhang W; Qi S; Zhuo J; Wen S; Fang C
    World J Surg; 2020 Jun; 44(6):1945-1953. PubMed ID: 32020325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise.
    Xu F; Sepúlveda MJ; Jiang Z; Wang H; Li J; Yin Y; Liu Z; Roebuck MC; Shortliffe EH; Yan M; Song Y; Geng C; Tang J; Rhee K
    JCO Clin Cancer Inform; 2019 Aug; 3():1-15. PubMed ID: 31419181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consistency of CSCO AI with Multidisciplinary Clinical Decision-Making Teams in Breast Cancer: A Retrospective Study.
    Xu W; Wang X; Yang L; Meng M; Sun C; Li W; Li J; Zheng L; Tang T; Jia W; Chen X
    Breast Cancer (Dove Med Press); 2024; 16():413-422. PubMed ID: 39099625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of case-based learning using Watson for oncology and traditional method in teaching undergraduate medical students.
    Zhao C; Xu T; Yao Y; Song Q; Xu B
    Int J Med Inform; 2023 Sep; 177():105117. PubMed ID: 37301132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Fidelity of Artificial Intelligence to Multidisciplinary Tumor Board Recommendations for Patients with Gastric Cancer: A Retrospective Study.
    Park YE; Chae H
    J Gastrointest Cancer; 2024 Mar; 55(1):365-372. PubMed ID: 37702851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial Intelligence-Driven Oncology Clinical Decision Support System for Multidisciplinary Teams.
    Lee K; Lee SH
    Sensors (Basel); 2020 Aug; 20(17):. PubMed ID: 32825296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology.
    Keikes L; Medlock S; van de Berg DJ; Zhang S; Guicherit OR; Punt CJA; van Oijen MGH
    J Clin Transl Res; 2018 Dec; 3(Suppl 3):411-423. PubMed ID: 30873490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Patient-Physician Concordance in the Understanding of Chemotherapy Treatment Plans Among Patients With Cancer.
    Almalki H; Absi A; Alghamdi A; Alsalmi M; Khan M
    JAMA Netw Open; 2020 Mar; 3(3):e200341. PubMed ID: 32125427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetings.
    Pattanasri M; Elder K; Nickson C; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Park A; De Boer R; Phillips C; Pridmore V; Farrugia H; Mann GB
    ANZ J Surg; 2018 Jan; ():. PubMed ID: 29363225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
    Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
    JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
    Hurria A; Wong FL; Pal S; Chung CT; Bhatia S; Mortimer J; Somlo G; Hurvitz S; Villaluna D; Naeim A
    Oncologist; 2009 Sep; 14(9):883-90. PubMed ID: 19726455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature.
    Drukker CA; van den Hout HC; Sonke GS; Brain E; Bonnefoi H; Cardoso F; Goldhirsch A; Harbeck N; Honkoop AH; Koornstra RH; van Laarhoven HW; Portielje JE; Schneeweiss A; Smorenburg CH; Stouthard J; Linn SC; Schmidt MK
    Eur J Cancer; 2014 Apr; 50(6):1045-54. PubMed ID: 24529927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.
    Pini TM; Hawley ST; Li Y; Katz SJ; Griggs JJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):867-74. PubMed ID: 22718307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.